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LETTERS TO THE EDITOR
Regarding “Stent grafts vs femoropopliteal bypass”
The randomized controlled trial (RCT) by Kedora et al1
showed that management of femoropopliteal (FP) arterial occlu-
sive disease using percutaneous treatment with an expanded poly-
tetrafluoroethylene (PTFE)/nitinol self-expanding stent graft was
comparable to surgical revascularization with conventional above
knee (AK)-FP bypass using synthetic material up to 12 months. In
the surgical bypass group, Dacron grafts were used in 64%, and
expanded PTFE was used in 36%. We would like to suggest,
however, that saphenous vein (SV) grafts should be used instead of
synthetic material as conduit of the FP bypass in the control group
because of the following reasons. According to themeta-analysis of
uncontrolled series by Pereira et al,2 SV grafts performed better
than PTFE grafts in AK-FP bypass. When only RCTs in the
systematic review of AK-FP bypass by Klinkert et al3 were consid-
ered, the patency of SV grafts was better than for PTFE grafts. The
most recent meta-analysis by us4 of currently available five RCTs
also demonstrated that SV grafts were superior to PTFE grafts in
AK-FP bypass: the pooled primary graft patency of SV and PTFE
grafts were 86.6% and 83.7% (P  .3957) at 1 year, 82.6% and
74.6% (P  .0198) at 2 years, 79.2% and 65.3% (P  .0011) at 3
years, 77.6% and 61.3% (P  .0001) at 4 years, and 76.4% and
56.1% (P  .0001) at 5 years, respectively. Because the type of
prosthetic (Dacron or PTFE) used for AK-FP bypass, grafts did not
affect 5-year patency rates in the RCT by Green et al,5 SV grafts
probably surpass both Dacron and PTFE grafts in patency of
AK-FP bypass. Therefore, to compare the efficacy of the stent graft
vs open surgical AK-FP bypass, conduit of the bypass would be SV
rather than Dacron or PTFE. If a stent graft is not superior to, but
comparable to AK-FP bypass using synthetic material, it might be
inferior to the bypass using SV grafts.
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Reply
The response by Dr Takagi and his associates to our recent
publication “Randomized comparison of percutaneous Viabahn
stent grafts vs prosthetic femoral-popliteal bypass in the treatment
of superficial femoral arterial occlusive disease” is appreciated. The
comments bring to the forefront important comparisons of the
treatment of superficial femoral arterial occlusive disease with
prosthetic conduit versus vein conduit. The analysis and articles
that are cited certainly offer good argument for vein conduit as the
“gold standard” in vascular revascularization of superficial femoral
artery (SFA) occlusion and limb ischemia. In fact, in our recent
article, we acknowledge that our group also considers vein conduit
as the “gold standard” for this type of reconstruction.
Our current study, however, was not designed to compare
venous reconstruction of the SFA with a percutaneous nitinol
self-expanding stent graft covered with polytetrafluoroethylene
(PTFE). It was designed to compare this type of stent graft with
nonautologous conduit. This type of reconstruction would be of
particular benefit for the patient population that cannot undergo
revascularization with venous conduit. There are numerous pa-
tients who present with no venous conduit useable for bypass or
who may not be suitable surgical candidates. We conducted our
study to evaluate this percutaneous method of treatment of the
SFA to offer another treatment option besides surgical bypass
using prosthetic conduit.
As is demonstrated in our study, percutaneous treatment of
the SFA with a covered nitinol self-expanding stent graft is shown
to be equal to surgical bypass of the SFA with nonautologous
conduit up to 12 months. In addition, there is a faster return to
daily activities and a decreased hospital stay. We believe these
results to show promise, although longer follow-up is needed and
is currently in process at our institution. Any treatment method
must be individualized for each patient and, if possible, we agree
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Regarding “Angio-Seal arterial puncture closing
device removal: some technical details”
In the article by Dregelid et al,1 the authors present a series of
four female patients affected by severe lower extremity ischemia
after use of Angio-Seal device, focusing on the importance of an
early detection of possible complications, such as thrombosis and
lower limb ischemia. However, from this article and from extensive
research in the English literature, in our opinion, there is no
consensus regarding the correct approach to remove the device in
case of complications.
In the light of our experience, a longitudinal arteriotomy
could not be always the method of choice to better approach the
arterial lesion, but should be reserved for selective cases when a
diffuse atherosclerotic involvement is present, or an extensive
injury of the intimal layer is supposed, such as in the case one of this
article.2 In fact, the arterial occlusion is often due to the thrombo-
sis around the Angio-Seal polymer bar in a stenotic tract of artery,
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